metahexamide

{{chembox

| Verifiedfields = changed

| Watchedfields = changed

| verifiedrevid = 444473742

| ImageFile=Metahexamide.svg

| ImageSize = 250

| PIN = 3-Amino-N-(cyclohexylcarbamoyl)-4-methylbenzene-1-sulfonamide

| OtherNames =

| Section1 = {{Chembox Identifiers

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = T3U6F5D722

| CASNo_Ref = {{cascite|correct|??}}

| CASNo = 565-33-3

| PubChem = 11259

| SMILES = CC1=C(C=C(C=C1)S(=O)(=O)NC(=O)NC2CCCCC2)N

| ChEMBL_Ref = {{ebicite|changed|EBI}}

| ChEMBL = 507419

| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}

| ChemSpiderID = 10785

| InChI = 1/C14H21N3O3S/c1-10-7-8-12(9-13(10)15)21(19,20)17-14(18)16-11-5-3-2-4-6-11/h7-9,11H,2-6,15H2,1H3,(H2,16,17,18)

| InChIKey = XXYTXQGCRQLRHA-UHFFFAOYAB

| StdInChI_Ref = {{stdinchicite|changed|chemspider}}

| StdInChI = 1S/C14H21N3O3S/c1-10-7-8-12(9-13(10)15)21(19,20)17-14(18)16-11-5-3-2-4-6-11/h7-9,11H,2-6,15H2,1H3,(H2,16,17,18)

| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}

| StdInChIKey = XXYTXQGCRQLRHA-UHFFFAOYSA-N

| RTECS =

| MeSHName =

| ChEBI =

| KEGG_Ref = {{keggcite|changed|kegg}}

| KEGG = D07117

}}

| Section2 = {{Chembox Properties

| Formula = C₁₄H₂₁N₃O₃S

| MolarMass = 311.4 g/mol

| Appearance =

| Density =

| MeltingPt =

| BoilingPt =

| Solubility =

}}

| Section6 = {{Chembox Pharmacology

| ATCCode_prefix = A10

| ATCCode_suffix = BB10

}}

| Section7 = {{Chembox Hazards

| MainHazards =

| FlashPt =

| AutoignitionPt =

}}

}}

Metahexamide (INN) is an anti-diabetic drug from the group of sulfonylureas. It is long-acting and belongs to the first-generation cyclohexyl-containing sulfonylureas. It was first described in 1959.{{cite journal |doi=10.1111/j.1749-6632.1959.tb44940.x |vauthors=Moss JM, Delawter D |title=Metahexamide in diabetes therapy |journal=Ann NY Acad Sci |volume=82 |issue= 2|pages=614–7 |date=September 1959 |pmid=14424617|bibcode=1959NYASA..82..614M }}